|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01875 TOT BIOPHARM-B
Nominal 
2.000 +0.050 (+2.564%) Non-current Assets
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Investment Properties | 2,585 | -7.181% | 2,785 | 3,184 | 3,583 | 0 |
| Property, plant, equip. & others | 708,971 | 1.892% | 695,804 | 465,328 | 307,668 | 290,367 |
| Land & other Lease Assets | 13,522 | -5.162% | 14,258 | 15,007 | 15,733 | 20,639 |
| Intangible Assets | 8,086 | -8.519% | 8,839 | 4,648 | 5,123 | 3,229 |
| Interests in Asso. & JCEs | 0 | -- | 0 | 0 | 1,483 | 0 |
| Other Non-current Assets | 3,170 | -71.797% | 11,240 | 97,067 | 70,710 | 77,721 |
| 736,334 | 0.465% | 732,926 | 585,234 | 404,300 | 391,956 | |
Current Assets
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Inventories | 114,044 | -9.495% | 126,009 | 94,821 | 29,558 | 8,114 | |
| Trade Receivables | 118,357 | 37.963% | 85,789 | 49,124 | 11,735 | 1,536 | |
| Cash & Bank Balances | 348,350 | -0.924% | 351,600 | 417,769 | 152,805 | 225,533 | |
| Other Current Assets | 139,569 | 7.545% | 129,777 | 115,083 | 111,865 | 14,044 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | |
| 720,320 | 3.916% | 693,175 | 676,797 | 305,963 | 249,227 | ||
Current Liabilities
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||
| Trade Payables | 30,317 | -15.102% | 35,710 | 25,983 | 28,214 | 18,006 | ||
| S-T Debt & Leases | 68,839 | 60.944% | 42,772 | 77,051 | 147,654 | 1,323 | ||
| Other Current Liabilities | 272,877 | -10.239% | 304,004 | 172,313 | 84,940 | 33,414 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | 0 | 0 | ||
| 372,033 | -2.733% | 382,486 | 275,347 | 260,808 | 52,743 | |||
| Net Current Assets | 348,287 | 12.101% | 310,689 | 401,450 | 45,155 | 196,484 | ||
| Total Assets Less Current Liabilities | 1,084,621 | 3.929% | 1,043,615 | 986,684 | 449,455 | 588,440 | ||
Non-current Liabilities
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||||
| L-T Debt & Leases | 315,042 | 4.016% | 302,879 | 212,478 | 60,911 | 6,083 | |||
| Other Non-current Liabilities | 45,692 | -15.463% | 54,050 | 58,767 | 53,453 | 0 | |||
| 360,734 | 1.066% | 356,929 | 271,245 | 114,364 | 6,083 | ||||
Capital and Reserves
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |||||
| Share Capital | 2,297,499 | 0.000% | 2,297,499 | 2,297,499 | 1,892,906 | 1,874,438 | ||||
| Reserves | (1,573,612) | -2.309% | (1,610,813) | (1,583,617) | (1,557,815) | (1,292,081) | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| Shareholders' Funds | 723,887 | 5.417% | 686,686 | 713,882 | 335,091 | 582,357 | ||||
| Non-controlling Interests | 0 | -- | 0 | 1,557 | 0 | 0 | ||||
| Others | 0 | -- | 0 | 0 | 0 | 0 | ||||
| 723,887 | 5.417% | 686,686 | 715,439 | 335,091 | 582,357 | |||||
Commitments and Contingent Liabilities
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Commitments | -- | -- | 82,665 | 147,050 | 187,799 | 7,094 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 30/09/2024 15:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 31,559,000 |
| %Change | -- |
| EPS / (LPS) | RMB 0.040 |
| NBV Per Share (¥) | RMB 0.937 |